Latest Insider Transactions at Puma Biotechnology, Inc. (PBYI)
This section provides a real-time view of insider transactions for Puma Biotechnology, Inc. (PBYI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PUMA BIOTECHNOLOGY, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PUMA BIOTECHNOLOGY, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2022
|
Adrian Senderowicz Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+32.98%
|
-
|
|
Jun 14
2022
|
Troy Edward Wilson Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+32.84%
|
-
|
|
Jun 14
2022
|
Michael Patrick Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+25.27%
|
-
|
|
Jun 14
2022
|
Brian M Stuglik Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+32.98%
|
-
|
|
Jun 02
2022
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
1,200
-0.02%
|
$1,200
$1.94 P/Share
|
|
Jun 02
2022
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
417
-0.51%
|
$417
$1.94 P/Share
|
|
Jun 02
2022
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
162
-0.13%
|
$162
$1.92 P/Share
|
|
Jun 02
2022
|
Alvin F Wong Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
587
-0.95%
|
$587
$1.92 P/Share
|
|
May 03
2022
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
438
-0.53%
|
$876
$2.31 P/Share
|
|
May 03
2022
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
1,263
-0.02%
|
$2,526
$2.32 P/Share
|
|
May 03
2022
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
165
-0.14%
|
$330
$2.34 P/Share
|
|
Apr 04
2022
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
206
-0.17%
|
$618
$3.08 P/Share
|
|
Apr 04
2022
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
413
-0.5%
|
$1,239
$3.08 P/Share
|
|
Apr 04
2022
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
1,198
-0.02%
|
$3,594
$3.08 P/Share
|
|
Mar 16
2022
|
Michael Patrick Miller Director |
SELL
Open market or private sale
|
Direct |
25,653
-32.67%
|
$51,306
$2.8 P/Share
|
|
Mar 10
2022
|
Alan H Auerbach President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,792,114
+22.02%
|
$3,584,228
$2.79 P/Share
|
|
Mar 03
2022
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,118
+35.7%
|
-
|
|
Mar 03
2022
|
Alvin F Wong Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,882
+41.98%
|
-
|
|
Mar 03
2022
|
Maximo F Nougues Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,176
+33.83%
|
-
|
|
Mar 03
2022
|
Douglas M Hunt Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,647
+21.49%
|
-
|
|
Mar 03
2022
|
Alan H Auerbach President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
168,824
+3.57%
|
-
|
|
Mar 02
2022
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
1,294
-0.03%
|
$2,588
$2.26 P/Share
|
|
Mar 02
2022
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
446
-0.74%
|
$892
$2.26 P/Share
|
|
Mar 02
2022
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
169
-0.28%
|
$338
$2.26 P/Share
|
|
Feb 02
2022
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
1,316
-0.03%
|
$2,632
$2.46 P/Share
|
|
Feb 02
2022
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
199
-0.33%
|
$398
$2.48 P/Share
|
|
Feb 02
2022
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
533
-0.87%
|
$1,066
$2.47 P/Share
|
|
Jan 03
2022
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,484
-11.12%
|
$22,452
$3.19 P/Share
|
|
Jan 03
2022
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
22,875
-0.52%
|
$68,625
$3.19 P/Share
|
|
Jan 03
2022
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
3,707
-5.72%
|
$11,121
$3.21 P/Share
|
|
Jan 03
2022
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,727
-13.11%
|
$14,181
$3.2 P/Share
|
|
Dec 02
2021
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
1,837
-0.04%
|
$3,674
$2.9 P/Share
|
|
Dec 02
2021
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
162
-0.24%
|
$324
$2.95 P/Share
|
|
Dec 02
2021
|
Alvin F Wong Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,131
-6.19%
|
$2,262
$2.91 P/Share
|
|
Dec 02
2021
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
441
-0.68%
|
$882
$2.9 P/Share
|
|
Nov 02
2021
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
1,795
-0.04%
|
$8,975
$5.63 P/Share
|
|
Nov 02
2021
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
427
-0.65%
|
$2,135
$5.64 P/Share
|
|
Nov 02
2021
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
156
-0.23%
|
$780
$5.67 P/Share
|
|
Oct 04
2021
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
1,858
-0.04%
|
$11,148
$6.15 P/Share
|
|
Oct 04
2021
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
443
-0.67%
|
$2,658
$6.15 P/Share
|
|
Oct 04
2021
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
161
-0.24%
|
$966
$6.2 P/Share
|
|
Sep 02
2021
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
422
-0.63%
|
$2,954
$7.52 P/Share
|
|
Sep 02
2021
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
155
-0.23%
|
$1,085
$7.51 P/Share
|
|
Sep 02
2021
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
1,764
-0.04%
|
$12,348
$7.6 P/Share
|
|
Aug 02
2021
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
1,764
-0.04%
|
$12,348
$7.53 P/Share
|
|
Aug 02
2021
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
420
-0.63%
|
$2,940
$7.53 P/Share
|
|
Aug 02
2021
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
154
-0.23%
|
$1,078
$7.54 P/Share
|
|
Jul 02
2021
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
1,016
-1.5%
|
$9,144
$9.15 P/Share
|
|
Jul 02
2021
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
155
-0.23%
|
$1,395
$9.26 P/Share
|
|
Jul 02
2021
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
5,332
-0.12%
|
$42,656
$8.84 P/Share
|